1. No category

2015 Production Schedule
Trialscape maps are published based on
all trial timing projections. We also offer
Citeline’s editorial calendar to accommodate
discounted Full Portfolio pricing that includes
the inclusion of data from major conferences
access to every map included in the therapeutic
and anticipated industry events.
area. Upon purchase, all Trialscape maps are
You may purchase Trialscape maps singly or
as annual subscriptions that include a base
map plus two updates (for a total of three
releases). Every update involves a full
reassessment of the trials landscape and
includes the addition of all new trials that fit
the map criteria and full review/analysis of
made available enterprise-wide for download
through Trialtrove.
For interest in areas beyond this list, customized
options are available. Our analysts will work
with you to create a deliverable that is tailored
to your needs. To order, contact your account
manager or email [email protected].
Autoimmune/Inflammation
Biosimilars of Adalimumab in Autoimmune/Inflammation, All Phases (New)
Feb-15
Jul-15
Feb-16
Pipeline Biologics in Psoriasis, Phase III
Apr-15
Oct-15
Apr-16
Pipeline Biologics in Asthma, Phase III (New)
Jun-15
Oct-15
Jun-16
Pipeline Biologics in Rheumatoid Arthritis, Phase III
Jul-15
Nov-15
Jul-16
Pipeline Kinase Inhibitors in Rheumatoid Arthritis, Phases II - III
Jul-15
Nov-15
Jul-16
PCSK9 Inhibitors in Dyslipidemia, Phase III - IV
Apr-15
Nov-15
Apr-16
Pipeline drugs for Congestive Heart Failure, Phase III
Apr-15
Nov-15
Apr-16
CV trials in China, Phase II - III (New)
Apr-15
Nov-15
Apr-16
Beta Amyloid Antagonists/Inhibitors in Alzheimer’s Disease, Phases II - III
Apr-15
Nov-15
Apr-16
Mild Cognitive Impairment in Alzheimer’s Disease, Phases II-III (New)
Apr-15
Nov-15
Apr-16
Oral Agents in Multiple Sclerosis, Phases II - III
May-15
Nov-15
May-16
Pipeline Drugs for Major Depressive Disorder, Phase III
Jun-15
Nov-15
Jun-16
Chronic Neuropathic Pain, Phase III
Jun-15
Oct-15
Jun-16
Cardiovascular
Central Nervous System
2015 Production Schedule
Infectious Disease & Genitourinary
Pipeline Drugs for Respiratory Synctial Virus, Phase II-III (New)
Jan-15
Jul-15
Feb-16
HCV Direct Acting Antivirals (DAAs) - Combination Trials, Phase III
Mar-15
Sep-15
Jan-16
Antibiotic Trials with Drugs Granted the QIDP Designation
May-15
Oct-15
Mar-16
Pipeline drugs for Anemia, Phase II (New)
Mar-15
Sep-15
Feb-16
Pipeline drugs for Anemia, Phase III (New)
Mar-15
Sep-15
Feb-16
Type 2 Diabetes CV Outcomes (New)
Mar-15
Sep-15
Feb-16
Pancreatic Cancer Therapies, Phase III
Jan-15
Aug-15
Jan-16
Breast Cancer First Line Therapies, Phase III
Jan-15
Sep-15
Jan-16
Breast Cancer Second Line or greater Therapies, Phase III
Jan-15
Sep-15
Jan-16
Biosimilars in Oncology - Hematological Cancers, All phases
Feb-15
Jul-15
Feb-16
Biosimilars in Oncology - Solid Tumors, All phases
Feb-15
Jul-15
Feb-16
Checkpoint Inhibitors in Oncology, Phase III (New)
Mar-15
Sep-15
Mar-16
ADC’s in Oncology, Phase III
Mar-15
Jul-15
Mar-16
Hormone Refractory Prostate Cancer Therapies, Phase III
Apr-15
Oct-15
Apr-16
Non-Small Cell Lung Cancer First Line Therapies, Phase III
Jul-15
Nov-15
Jul-16
Non-Small Cell Lung Cancer Second Line or greater Therapies, Phase III
Jul-15
Nov-15
Jul-16
Metabolic/Endocrinology
Oncology
www.citeline.com
Citeline © 2015. All rights reserved.